Abstract
Xenografts derived from the neoplastic tissues of children with rhabdomyosarcoma have been used in immune-deprived mice to examine the efficacy of agents known to be active against this disease, and in others that received either limited of no clinical evaluation. Two models were derived; xenografts were established from tumors obtained from either (a) untreated patients or (b) from patients who had become refractory to conventional therapy. Model a identified as being effective each of these clinically used agents: vincristine, dactinomycin, cyclophosphamide, and doxorubicin; mitomycin C and 5-(3,3-dimethyl-1 -triazeno)-2-methylimidazole-4-carboxamide also showed activity, as did busulfan in one tumor line. Tumors derived from refractory patients were significantly less responsive to all agents examined.
Original language | English (US) |
---|---|
Pages (from-to) | 535-539 |
Number of pages | 5 |
Journal | Cancer Research |
Volume | 42 |
Issue number | 2 |
State | Published - Feb 1 1982 |
Externally published | Yes |
ASJC Scopus subject areas
- Oncology
- Cancer Research